Literature DB >> 25258369

Combining MRI with NIHSS thresholds to predict outcome in acute ischemic stroke: value for patient selection.

P W Schaefer1, B Pulli2, W A Copen2, J A Hirsch2, T Leslie-Mazwi2, L H Schwamm3, O Wu2, R G González2, A J Yoo2.   

Abstract

BACKGROUND AND
PURPOSE: Selecting acute ischemic stroke patients for reperfusion therapy on the basis of a diffusion-perfusion mismatch has not been uniformly proved to predict a beneficial treatment response. In a prior study, we have shown that combining clinical with MR imaging thresholds can predict clinical outcome with high positive predictive value. In this study, we sought to validate this predictive model in a larger patient cohort and evaluate the effects of reperfusion therapy and stroke side.
MATERIALS AND METHODS: One hundred twenty-three consecutive patients with anterior circulation acute ischemic stroke underwent MR imaging within 6 hours of stroke onset. DWI and PWI volumes were measured. Lesion volume and NIHSS score thresholds were used in models predicting good 3-month clinical outcome (mRS 0-2). Patients were stratified by treatment and stroke side.
RESULTS: Receiver operating characteristic analysis demonstrated 95.6% and 100% specificity for DWI > 70 mL and NIHSS score > 20 to predict poor outcome, and 92.7% and 91.3% specificity for PWI (mean transit time) < 50 mL and NIHSS score < 8 to predict good outcome. Combining clinical and imaging thresholds led to an 88.8% (71/80) positive predictive value with a 65.0% (80/123) prognostic yield. One hundred percent specific thresholds for DWI (103 versus 31 mL) and NIHSS score (20 versus 17) to predict poor outcome were significantly higher in treated (intravenous and/or intra-arterial) versus untreated patients. Prognostic yield was lower in right- versus left-sided strokes for all thresholds (10.4%-20.7% versus 16.9%-40.0%). Patients with right-sided strokes had higher 100% specific DWI (103.1 versus 74.8 mL) thresholds for poor outcome, and the positive predictive value was lower.
CONCLUSIONS: Our predictive model is validated in a much larger patient cohort. Outcome may be predicted in up to two-thirds of patients, and thresholds are affected by stroke side and reperfusion therapy.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 25258369      PMCID: PMC4462135          DOI: 10.3174/ajnr.A4103

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix.

Authors:  Ona Wu; Leif Østergaard; Robert M Weisskoff; Thomas Benner; Bruce R Rosen; A Gregory Sorensen
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

2.  Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis.

Authors:  Daniel Sanák; Vladimír Nosál'; David Horák; Andrea Bártková; Kamil Zelenák; Roman Herzig; Jirí Bucil; David Skoloudík; Stanislav Burval; Viera Cisariková; Ivanka Vlachová; Martin Köcher; Jana Zapletalová; Egon Kurca; Petr Kanovský
Journal:  Neuroradiology       Date:  2006-08-29       Impact factor: 2.804

3.  Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.

Authors:  D Cocho; R Belvís; J Martí-Fàbregas; L Molina-Porcel; J Díaz-Manera; A Aleu; J Pagonabarraga; D García-Bargo; A Mauri; J-L Martí-Vilalta
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

4.  The ischemic penumbra: operationally defined by diffusion and perfusion MRI.

Authors:  G Schlaug; A Benfield; A E Baird; B Siewert; K O Lövblad; R A Parker; R R Edelman; S Warach
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

5.  Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials.

Authors:  T J DeGraba; J M Hallenbeck; K D Pettigrew; A J Dutka; B J Kelly
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

6.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

7.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

Authors:  Stephen M Davis; Geoffrey A Donnan; Mark W Parsons; Christopher Levi; Kenneth S Butcher; Andre Peeters; P Alan Barber; Christopher Bladin; Deidre A De Silva; Graham Byrnes; Jonathan B Chalk; John N Fink; Thomas E Kimber; David Schultz; Peter J Hand; Judith Frayne; Graeme Hankey; Keith Muir; Richard Gerraty; Brian M Tress; Patricia M Desmond
Journal:  Lancet Neurol       Date:  2008-02-28       Impact factor: 44.182

10.  Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes.

Authors:  S Sato; K Toyoda; T Uehara; N Toratani; C Yokota; H Moriwaki; H Naritomi; K Minematsu
Journal:  Neurology       Date:  2008-04-23       Impact factor: 9.910

View more
  9 in total

1.  Effect of color visualization and display hardware on the visual assessment of pseudocolor medical images.

Authors:  Silvina Zabala-Travers; Mina Choi; Wei-Chung Cheng; Aldo Badano
Journal:  Med Phys       Date:  2015-06       Impact factor: 4.071

2.  Magnetic resonance post-contrast vascular hyperintensities at 3 T: a new highly sensitive sign of vascular occlusion in acute ischaemic stroke.

Authors:  Loïc Duron; Julien Savatovsky; Michael Obadia; Marie Astrid Metten; Pascal Roux; Raphael Blanc; Jean-Claude Sadik; Sarah Dhundass; Augustin Lecler
Journal:  Eur Radiol       Date:  2018-02-09       Impact factor: 5.315

3.  MRI patient selection for endovascular thrombectomy in acute ischemic stroke: correlation between pretreatment diffusion weighted imaging and outcome scores.

Authors:  Marcello Longo; Gianmarco Bernava; Alessandro Calamuneri; Antonio A Caragliano; Antonio Pitrone; Rosario Papa; Enricomaria Mormina; Francesca Granata; Rosa Musolino; Agostino Tessitore; Giuseppe Centorrino; Federico Midiri; Federica Vernuccio; Sergio L Vinci
Journal:  Radiol Med       Date:  2018-04-16       Impact factor: 3.469

4.  Distance to thrombus on MR angiography predicts outcome of middle cerebral artery occlusion treated with IV thrombolysis.

Authors:  Matthias Gawlitza; Benjamin Friedrich; Ulf Quäschling; Stefan Schob; Alexander Schaudinn; Carsten Hobohm; Karl-Titus Hoffmann; Donald Lobsien
Journal:  Neuroradiology       Date:  2015-07-11       Impact factor: 2.804

5.  Blood Glutamate Levels Are Closely Related to Acute Lung Injury and Prognosis after Stroke.

Authors:  Wei Bai; Wei Li; Ya-Lei Ning; Ping Li; Yan Zhao; Nan Yang; Yu-Lin Jiang; Ze-Ping Liang; Dong-Po Jiang; Ying Wang; Meng Zhang; Yuan-Guo Zhou
Journal:  Front Neurol       Date:  2018-01-19       Impact factor: 4.003

6.  Boundary and vulnerability estimation of the internal borderzone using ischemic stroke lesion mapping.

Authors:  Sylvain Grange; Rémi Grange; Pierre Garnier; Jérôme Varvat; Doina Marinescu; Fabrice-Guy Barral; Claire Boutet; Fabien C Schneider
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

7.  Clinical effect of minimally invasive aspiration and drainage of intracranial hematoma in the treatment of cerebral hemorrhage.

Authors:  Chao Deng; Yuanling Ji; Wei Song; Jingfang Bi
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

8.  Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke.

Authors:  Grant Mair; Rüdiger von Kummer; Zoe Morris; Anders von Heijne; Nick Bradey; Lesley Cala; André Peeters; Andrew J Farrall; Alessandro Adami; Gillian Potter; Peter A G Sandercock; Richard I Lindley; Joanna M Wardlaw
Journal:  Neurology       Date:  2018-10-26       Impact factor: 9.910

9.  Predictive values of CSS and NIHSS in the prognosis of patients with acute cerebral infarction: A comparative analysis.

Authors:  Xiao-Jing Zhao; Qun-Xi Li; Tie-Jun Liu; Da-Li Wang; Ya-Chen An; Jiang Zhang; Yan-Bo Peng; Rui-Ying Chen; Li-Sha Chang; Yan Wang; Li Zhang; Hai-Yan Fan; Xiu-Jie Wang; Fu-Xia Zheng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.